Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sugy Choi, Shannon Healy, Liudmila Shapoval, Sarah Forthal & Charles J. Neighbors. (2021) Hepatitis C Virus Screening among Medicaid-Insured Individuals with Opioid Use Disorder across Substance Use Disorder Treatment Settings. Substance Use & Misuse 56:2, pages 258-263.
Read now
Read now
Articles from other publishers (23)
Myles Finlay, Julie A. Erwin, Lillian Skeiky, Devon A. Hansen, Matthew E. Layton, Raymond Quock, Hans P. A. Van Dongen & Marian Wilson. (2023) Nighttime Sleep and Respiratory Disturbances in Individuals Receiving Methadone to Treat Opioid Use Disorder. Journal of Addictions Nursing 34:4, pages E180-E188.
Crossref
Crossref
Louisa Degenhardt, Brodie Clark, Georgina Macpherson, Oscar Leppan, Suzanne Nielsen, Emma Zahra, Briony Larance, Jo Kimber, Daniel Martino-Burke, Matthew Hickman & Michael Farrell. (2023) Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies. The Lancet Psychiatry 10:6, pages 386-402.
Crossref
Crossref
Monica Rivera Mindt, Kelly Coulehan, Maral Aghvinian, Travis M. Scott, James Patrick Olsen, Chinazo O. Cunningham, Franchesca Arias & Julia H. Arnsten. (2022) Underrepresentation of diverse populations and clinical characterization in opioid agonist treatment research: A systematic review of the neurocognitive effects of buprenorphine and methadone treatment. Journal of Substance Abuse Treatment 135, pages 108644.
Crossref
Crossref
Skyler H. Kessler, Evan S. Schwarz & David B. Liss. (2021) Methadone vs. Buprenorphine for In-Hospital Initiation: Which Is Better for Outpatient Care Retention in Patients with Opioid Use Disorder?. Journal of Medical Toxicology 18:1, pages 11-18.
Crossref
Crossref
Noa Krawczyk, Arthur Robin Williams, Brendan Saloner & Magdalena Cerdá. (2021) Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings. Journal of Substance Abuse Treatment 126, pages 108329.
Crossref
Crossref
Paul J. Joudrey, Zoe M. Adams, Paxton Bach, Sarah Van Buren, Jessica A. Chaiton, Lucy Ehrenfeld, Mary Elizabeth Guerra, Brynna Gleeson, Simeon D. Kimmel, Ashley Medley, Wassim Mekideche, Maxime Paquet, Minhee Sung, Melinda Wang, R. O. Olivier You Kheang, Jingxian Zhang, Emily A. Wang & E. Jennifer Edelman. (2021) Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada. JAMA Network Open 4:7, pages e2118223.
Crossref
Crossref
Alexandria Macmadu, Joëlla W. Adams, S.E. Bessey, Lauren Brinkley-Rubinstein, Rosemarie A. Martin, Jennifer G. Clarke, Traci C. Green, Josiah D. Rich & Brandon D.L. Marshall. (2021) Optimizing the impact of medications for opioid use disorder at release from prison and jail settings: A microsimulation modeling study. International Journal of Drug Policy 91, pages 102841.
Crossref
Crossref
Judith I. Tsui, Mary A. Akosile, Gwen T. Lapham, Denise M. Boudreau, Eric A. Johnson, Jennifer F. Bobb, Ingrid A. Binswanger, Bobbi Jo H. Yarborough, Joseph E. Glass, Rebecca C. Rossom, Mark T. Murphy, Chinazo O. Cunningham, Julia H. Arnsten, Manu Thakral, Andrew J. Saxon, Joseph O. Merrill, Jeffrey H. Samet, Gavin B. Bart, Cynthia I. Campbell, Amy M. Loree, Angela Silva, Angela L. Stotts, Brian Ahmedani, Jordan M Braciszewski, Rulin C. Hechter, Thomas F. Northrup, Viviana E. Horigian & Katharine A. Bradley. (2021) Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV. Journal of General Internal Medicine 36:4, pages 930-937.
Crossref
Crossref
Mirinda Ann Gormley, Courtney T Blondino, DaShaunda D H Taylor, Elizabeth Lowery, James S Clifford, Benjamin Burkart, Whitney C Graves, Elizabeth C Prom-Wormley & Juan Lu. (2020) Assessment of Co-Occurring Substance Use During Opiate Treatment Programs in the United States. Epidemiologic Reviews 42:1, pages 79-102.
Crossref
Crossref
Elizabeth A. Evans, Caroline Yoo, David Huang, Andrew J. Saxon & Yih-Ing Hser. (2019) Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2 years: Results from a multisite randomized trial of adults with opioid use disorder. Journal of Substance Abuse Treatment 106, pages 19-28.
Crossref
Crossref
Rachel Springer, Miguel Marino, Steffani R. Bailey, Heather Angier, Jean P. O'Malley, Megan Hoopes, Stephan Lindner, Jennifer E. DeVoe & Nathalie Huguet. (2019) Prescription opioid use patterns, use disorder diagnoses and addiction treatment receipt after the 2014 Medicaid expansion in Oregon. Addiction 114:10, pages 1775-1784.
Crossref
Crossref
Kathleen M. CarrollRoger D. Weiss. (2019) The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review. FOCUS 17:2, pages 183-192.
Crossref
Crossref
An Thi Minh Dao, Huong Thi Thu Nguyen & Long Hoang Nguyen. (2018) Variation Overtime among Patients of the Six Methadone Maintenance Treatment Clinics in Thai Nguyen from 2011 to 2015. BioMed Research International 2018, pages 1-7.
Crossref
Crossref
Zoe M. Weinstein, Gabriela Gryczynski, Debbie M. Cheng, Emily Quinn, David Hui, Hyunjoong W. Kim, Colleen Labelle & Jeffrey H. Samet. (2018) Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program. Drug and Alcohol Dependence 189, pages 166-171.
Crossref
Crossref
Kelly E. Dunn, Patrick H. Finan, D. Andrew Tompkins & Eric C. Strain. (2018) Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients. Addictive Behaviors 76, pages 8-14.
Crossref
Crossref
Matthew Daubresse, Brendan Saloner, Harold A. Pollack & G. Caleb Alexander. (2017) Non‐buprenorphine opioid utilization among patients using buprenorphine. Addiction 112:6, pages 1045-1053.
Crossref
Crossref
Fabio Lugoboni, Frances Rudnick Levin, Maria Chiara Pieri, Matteo Manfredini, Lorenzo Zamboni, Lorenzo Somaini, Gilberto Gerra & Gruppo InterSert Collaborazione Scientifica (GICS). (2017) Co-occurring Attention Deficit Hyperactivity Disorder symptoms in adults affected by heroin dependence: Patients characteristics and treatment needs. Psychiatry Research 250, pages 210-216.
Crossref
Crossref
Zoe M. Weinstein, Hyunjoong W. Kim, Debbie M. Cheng, Emily Quinn, David Hui, Colleen T. Labelle, Mari-Lynn Drainoni, Sara S. Bachman & Jeffrey H. Samet. (2017) Long-term retention in Office Based Opioid Treatment with buprenorphine. Journal of Substance Abuse Treatment 74, pages 65-70.
Crossref
Crossref
Katelyn J. Carey, Wei Huang, Benjamin P. Linas & Judith I. Tsui. (2016) Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders. Journal of Substance Abuse Treatment 66, pages 54-59.
Crossref
Crossref
Kinna Thakarar, Zoe M Weinstein & Alexander Y Walley. (2016) Optimising health and safety of people who inject drugs during transition from acute to outpatient care: narrative review with clinical checklist. Postgraduate Medical Journal 92:1088, pages 356-363.
Crossref
Crossref
Ajay Manhapra, Lantie Quinones & Robert Rosenheck. (2016) Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration. Drug and Alcohol Dependence 160, pages 82-89.
Crossref
Crossref
Kelly E. Dunn, Patrick H. Finan, D. Andrew Tompkins, Michael Fingerhood & Eric C. Strain. (2015) Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients. Drug and Alcohol Dependence 157, pages 143-149.
Crossref
Crossref
Michael D. Stein, Celeste M. Caviness, Kristin Grimone, Daniel Audet, Allison Borges & Bradley J. Anderson. (2015) E-cigarette Knowledge, Attitudes, and Use in Opioid Dependent Smokers. Journal of Substance Abuse Treatment 52, pages 73-77.
Crossref
Crossref